Definition
An indicator of whether molecular pathology testing was performed to characterise a person's cancer, as represented by a code.
Components
Data Element (this item)
-
Data Element ConceptPerson with cancer—molecular pathology indicator
-
Object ClassPerson with cancer
-
PropertyMolecular pathology indicator
-
-
Value DomainYes/no/unknown code N
Representation
This representation is based on the value domain for this data element, more information is available at " Yes/no/unknown code N ".| Data Type | Number |
|---|---|
| Format | N |
| Maximum character length | 1 |
| Value | Meaning | Start Date | End Date | |
|---|---|---|---|---|
| Permissible Values | 1 | Yes | ||
| 2 | No | |||
| Supplementary Values | 8 | Unknown |
Comments
Guide for use:
Record whether or not molecular testing was performed on the biospecimen sample of a person with cancer. This should be collected for people with cancer where pathology data is available.
Comments:
Collected to identify the number of patients who undergo molecular testing. The presence of genetic or molecular abnormalities may be of clinical significance and influence treatment decisions.
References
Royal College of Pathologists of Australasia 2010. Lung cancer structured reporting protocol. 1st Edition (Version 1.0). Surry Hills, NSW: Royal College of Pathologists of Australasia
This content Based on Australian Institute of Health and Welfare material. Attribution provided as required under the AIHW CC-BY licence.
This content Based on Australian Institute of Health and Welfare material. Attribution provided as required under the AIHW CC-BY licence.